Acta Médica Portuguesa<p>AMP just published!<br />"Osimertinib: A Game-Changer in Stage IV EGFR-Driven Lung Cancer"</p><p>A Case Report by Sofia Silva, Joana Duarte, Carla Simão and Margarida Felizardo – A work from the Pulmonology Department at Hospital Beatriz Ângelo, in Lisbon, Portugal. </p><p>Full paper here:<br /><a href="https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/22031" target="_blank" rel="nofollow noopener noreferrer" translate="no"><span class="invisible">https://www.</span><span class="ellipsis">actamedicaportuguesa.com/revis</span><span class="invisible">ta/index.php/amp/article/view/22031</span></a></p><p><a href="https://masto.pt/tags/nonsmallcelllungcarcinoma" class="mention hashtag" rel="tag">#<span>nonsmallcelllungcarcinoma</span></a> <a href="https://masto.pt/tags/drugtherapy" class="mention hashtag" rel="tag">#<span>drugtherapy</span></a> <a href="https://masto.pt/tags/ErbBreceptors" class="mention hashtag" rel="tag">#<span>ErbBreceptors</span></a> <a href="https://masto.pt/tags/lungneoplasms" class="mention hashtag" rel="tag">#<span>lungneoplasms</span></a> <a href="https://masto.pt/tags/osimertinib" class="mention hashtag" rel="tag">#<span>osimertinib</span></a></p>